阅读说明：本技术 咪唑鎓氟磺酰亚胺离子粘合剂组合物及其选择性脱粘 (Imidazolium fluorosulfonylimide ionic binder compositions and selective debonding thereof ) 是由 史丹尼斯劳·瑞瓦尔 汀莎·姚 胡毓芬 张洪喜 王鹏 于 2018-11-20 设计创作，主要内容包括：粘合剂可包含至少一种式1的咪唑鎓阳离子和至少一种式2的氟磺酰亚胺阴离子。在这些式中：R<Sup>1</Sup>为氢,C<Sub>1</Sub>-C<Sub>3</Sub>烷基或任选取代的C<Sub>1</Sub>-C<Sub>12</Sub>烷基胺,R<Sup>3</Sup>各自独立地为C<Sub>1</Sub>-C<Sub>3</Sub>烷基或任选取代的C<Sub>1</Sub>-C<Sub>12</Sub>烷基胺,且R<Sup>2</Sup>、R<Sup>4</Sup>、R<Sup>5</Sup>各自独立地为氢或C<Sub>1</Sub>-C<Sub>3</Sub>烷基；<Image he="267" wi="700" file="DDA0002589090220000011.GIF" imgContent="drawing" imgFormat="GIF" orientation="portrait" inline="no"></Image>(The binder may comprise at least one imidazolium cation of formula 1 and at least one fluorosulfonylimide anion of formula 2. In these formulae: r 1 Is hydrogen, C 1 ‑C 3 Alkyl or optionally substituted C 1 ‑C 12 Alkylamines, R 3 Each independently is C 1 ‑C 3 Alkyl or optionally substituted C 1 ‑C 12 Alkylamine, and R 2 、R 4 、R 5 Each independently is hydrogen or C 1 ‑C 3 An alkyl group;)